Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-15

FDA Approved: PATADAY TWICE A DAY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application to Pataday Twice a Day Relief (olopatadine hydrochloride) from Alcon Laboratories, expanding the product's labeling for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PATADAY TWICE A DAY RELIEF (olopatadine hydrochloride)

Snippet

SUPPL AP for PATADAY TWICE A DAY RELIEF (OLOPATADINE HYDROCHLORIDE)